What Is Genetic Discrimination And Why It Matters?

Genetic discrimination happens when people are treated unfairly because of differences in their DNA that affect their health. It can affect whether you get a job, keep a job, or get health insurance. The fear of this discrimination has real consequences, including people skipping genetic tests that could catch disease early.

What Is Genetic Discrimination And Why It Matters

Genetic discrimination is the unfair treatment of a person based on their genetic information. This includes results from genetic tests, family medical history, or participation in genetic research. It matters because your DNA is not something you choose, and it should not be used to deny you opportunities or coverage.

Most people first encounter this issue when deciding whether to take a genetic test. For example, a woman with a strong family history of breast cancer might consider testing for the BRCA genes. If the test shows she carries a mutation, she faces a higher lifetime risk of breast and ovarian cancer. The question becomes: who will see this result, and what will they do with it?

The most common areas where genetic discrimination appears are employment and insurance. A person might be denied a job because a genetic test suggests they could develop a costly illness. Or an insurer might refuse coverage or raise premiums based on the same information. Both scenarios create a strong disincentive to learn about your own health risks.

What Laws Protect Against Genetic Discrimination

The main federal law in the United States is the Genetic Information Nondiscrimination Act, known as GINA. It was signed into law in 2008. GINA makes it illegal for health insurers to use genetic information to set premiums or deny coverage. It also prevents employers with 15 or more workers from using genetic information in hiring, firing, or promotion decisions.

GINA has clear limits that many people do not know about. It does not cover life insurance, disability insurance, or long-term care insurance. Those industries can still use genetic test results to make decisions. GINA also does not apply to employers with fewer than 15 employees, or to the military and certain federal programs.

Some states have their own laws that fill gaps left by GINA. State protections vary widely. A handful of states have laws covering life insurance discrimination, but most do not. If you are concerned about a specific type of insurance, you need to check the laws in your state rather than assuming GINA protects you everywhere.

How Genetic Information Actually Gets Used

Health insurers in the individual market cannot use genetic test results to deny coverage or charge more, thanks to GINA and the Affordable Care Act. But the information still flows into your medical record. Once it is there, other parties may have legal access to it under certain circumstances.

Employers who offer self-funded health plans may see aggregated health data, though not individual genetic results. This is a gray area. The plan administrator and the employer are technically separate, but the firewall between them is not always perfect in practice.

Life insurance companies ask about genetic testing on their applications. In most states, they can use a positive result for a serious condition to deny coverage or charge a higher premium. This is legal because GINA does not extend to life insurance. Some people choose not to get genetic testing specifically to keep their life insurance options open.

Researchers who study genetic data are governed by separate rules. The Genetic Information Nondiscrimination Act also applies to research settings in some ways, but the main protection for research participants comes from the Common Rule and institutional review boards. These require informed consent and data de-identification in most cases, but re-identification risks remain a topic of ongoing concern.

Why People Avoid Genetic Testing Out of Fear

Studies have consistently found that fear of discrimination keeps people from getting genetic tests. This is not a small effect. In surveys, a substantial portion of people at risk for hereditary conditions say they would decline testing if they worried about insurance or employment consequences.

This avoidance has direct health consequences. Genetic testing can guide prevention. A person who knows they carry a Lynch syndrome mutation, which raises colon cancer risk, might start colonoscopies earlier and more frequently. Skipping the test means missing that chance for early detection.

The fear is not always rational from a legal standpoint. GINA does protect against health insurance and employment discrimination in most cases. But the law is complex, and many people do not understand its exact scope. A 2020 review of public awareness found that most Americans had never heard of GINA or did not know what it covered.

Doctors face a difficult position. They may recommend a genetic test that could genuinely help a patient, but the patient refuses out of fear. When that happens, the conversation should include what GINA does and does not protect. Patients need accurate information to weigh the real risks and benefits, not vague fears or false reassurance.

How Genetic Discrimination Differs From Medical Privacy Concerns

Genetic discrimination is a specific type of privacy problem, but not the same as a general privacy breach. A breach means someone saw your data without permission. Discrimination means someone used your data to treat you differently. Both are serious, but they require different solutions.

Medical records are protected by HIPAA, the Health Insurance Portability and Accountability Act. HIPAA limits who can see your health information without your consent. But HIPAA does not stop an employer or insurer from asking about genetic tests directly. GINA fills that gap for health insurance and employment. For life insurance, no federal law fills the gap.

Another difference is that genetic information is uniquely identifying and permanent. Your genetic code does not change over time. A data breach involving your credit card can be fixed by canceling the card. A breach involving your genome cannot be undone. This permanence is part of why genetic data deserves special legal attention.

Direct-to-consumer genetic testing companies like 23andMe and Ancestry add another layer. When you send in a saliva sample, you agree to a privacy policy that may allow your de-identified data to be shared with research partners. Law enforcement has also used public genetic databases to identify suspects in criminal cases. These uses are separate from insurance discrimination but raise overlapping questions about consent and control.

What You Can Do to Protect Yourself

Before taking any genetic test, ask who will see the results. A clinical test ordered by your doctor goes into your medical record. A direct-to-consumer test may not, but its privacy policy determines how the company can use your data. Read that policy carefully.

If you are considering genetic testing and worried about life insurance, talk to the insurer first. Ask whether a positive result would affect your ability to get or keep a policy. In some cases, it may be wise to purchase life insurance before undergoing genetic testing. This is legal and does not require disclosing test results you have not yet received.

Consider genetic counseling before testing. A genetic counselor can explain what the test can and cannot tell you, who might see the results, and what legal protections apply. Many people find this helps them make a more informed decision without being paralyzed by fear.

Keep in mind that most genetic tests return negative or uncertain results. A negative result does not guarantee you will never develop the condition, just that you do not carry the specific mutation being tested. An uncertain result, called a variant of uncertain significance, means the lab found a change in your DNA but does not know if it affects your health. Neither of these results is likely to trigger discrimination.

What the Future Holds for Genetic Privacy

Genetic testing is becoming cheaper and more common. Whole genome sequencing is now available for under a thousand dollars in some settings. As testing expands, the volume of genetic data in medical records and research databases will grow. This increases both the potential benefits and the potential for misuse.

Some experts argue that GINA needs updating. It was written before direct-to-consumer testing became widespread and before genetic data became a routine part of medical care. The law does not address workplace wellness programs that offer genetic testing as an incentive, nor does it clearly cover employer access to data from wearable devices.

State-level efforts to close the life insurance gap have been slow. As of this writing, only a few states have passed laws restricting life insurers from using genetic test results. Federal action on this issue has not advanced. The legal landscape is likely to remain uneven for the foreseeable future.

Research into polygenic risk scores adds another layer of complexity. These scores estimate disease risk based on thousands of small genetic variations rather than a single mutation. It is not yet clear how insurers or employers will treat these scores. The science is still developing, and the legal framework has not caught up.